DE60103016D1 - Verwendung von alpha interferon zur behandlung von ewings sarcom - Google Patents

Verwendung von alpha interferon zur behandlung von ewings sarcom

Info

Publication number
DE60103016D1
DE60103016D1 DE60103016T DE60103016T DE60103016D1 DE 60103016 D1 DE60103016 D1 DE 60103016D1 DE 60103016 T DE60103016 T DE 60103016T DE 60103016 T DE60103016 T DE 60103016T DE 60103016 D1 DE60103016 D1 DE 60103016D1
Authority
DE
Germany
Prior art keywords
sarcom
ewings
treat
alpha interferon
interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60103016T
Other languages
English (en)
Other versions
DE60103016T2 (de
Inventor
Josiane Sanceau
Jeanne Wietzerbin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Curie
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Institut Curie filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of DE60103016D1 publication Critical patent/DE60103016D1/de
Application granted granted Critical
Publication of DE60103016T2 publication Critical patent/DE60103016T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60103016T 2000-01-19 2001-01-18 Verwendung von alpha interferon zur behandlung von ewings sarcom Expired - Lifetime DE60103016T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00400132 2000-01-19
EP00400132A EP1118330A1 (de) 2000-01-19 2000-01-19 Verwendung von Alpha Interferon zur Behandlung von Ewings Tumoren
PCT/IB2001/000044 WO2001052881A1 (en) 2000-01-19 2001-01-18 Interferon-alpha use in the treatment of ewing's family of tumors

Publications (2)

Publication Number Publication Date
DE60103016D1 true DE60103016D1 (de) 2004-06-03
DE60103016T2 DE60103016T2 (de) 2005-04-07

Family

ID=8173514

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60103016T Expired - Lifetime DE60103016T2 (de) 2000-01-19 2001-01-18 Verwendung von alpha interferon zur behandlung von ewings sarcom

Country Status (7)

Country Link
EP (2) EP1118330A1 (de)
AR (1) AR024823A1 (de)
AT (1) ATE265223T1 (de)
AU (1) AU2001223910A1 (de)
DE (1) DE60103016T2 (de)
ES (1) ES2220704T3 (de)
WO (1) WO2001052881A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153584A1 (de) * 2001-11-02 2003-05-15 Megamedics Gmbh Verfahren zur Indentifizierung Tumor-spezifischer Antigene auf Krebszellen
RU2482871C2 (ru) * 2010-06-07 2013-05-27 Общество с ограниченной ответственностью "Центр Инновационных Технологий "БиоФарм" (ООО "ЦИТ "БиоФарм") Композиция для лечения вирусных заболеваний животных

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2308373A1 (en) * 1997-11-07 1999-05-20 Mayo Foundation For Medical Education And Research Interferon immunotherapy

Also Published As

Publication number Publication date
AU2001223910A1 (en) 2001-07-31
EP1250147B1 (de) 2004-04-28
ATE265223T1 (de) 2004-05-15
AR024823A1 (es) 2002-10-30
ES2220704T3 (es) 2004-12-16
DE60103016T2 (de) 2005-04-07
EP1118330A1 (de) 2001-07-25
EP1250147A1 (de) 2002-10-23
WO2001052881A1 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
ATE308364T1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
ATE419856T1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
ATE288748T1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
ATE365042T1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
ATE307597T1 (de) Verwendung von peg-ifn-alpha und ribavirin zur behandlung chronischer hepatitis c
DE602004022061D1 (de) Verwendung von modifizierten cyclosporinen zur behandlung von hcv-erkrankungen
ATE257013T1 (de) Verwendung von botulinum-toxin zur behandlung von diabetes
ATE357440T1 (de) Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen
ATE338557T1 (de) Verwendung von cox2 inhibitoren zur behandlung von schizophrenia und des ticks
ATE353218T1 (de) Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis
ATE401309T1 (de) Verwendung von 2-fuoro-3-ketoestern zur herstellung von 3-fuoro-6,7,8,9-tetrahydro-4h- pyrimidoä1,2-aüpyrimidin-4-onen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE526982T1 (de) Verwendung von neublastin-polypeptide zur behandlung von neuropathischen schmerzen
DE60322898D1 (de) Verwendung von isoflavonen zur förderung des schlankheitseffekts
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
ATE254913T1 (de) Diacerein zur behandlung von psoriasis
ATE339955T1 (de) Verwendung von escitalopram zur behandlung von generalisierten angstzuständen
ATE417616T1 (de) Behandlung von mukositis
ATE218862T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE326969T1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
ATE317261T1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
ATE267608T1 (de) Verwendung von fsh zur behandlung von infertilität
ATE404203T1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
ATE418337T1 (de) Verwendung von dihydroimidazolonen zur behandlung von epilepsie bei hunden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition